Health Products

OraVerse Injection (2018-04-20)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
D01894D
Recalling Firm
N/A
Marketing Authorization Holder
SEPTODONT
OraVerse InjectionPowder for solutionDIN 02421666phentolamine mesylate Injection 0.4 mg/1.7 mL

Introduction

Affected Products

OraVerse Injection

Reason

Out of specification for phentolamine mesylate assay in lot D01894D. Out of trend for degradation product impurity (phentolamide) in lots D01894D and D01894F.

Depth of distribution

Wholesalers in ON, QC, AB and BC
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime